GENETIC TESTING for HEREDITARY CANCER SYNDROMES Resource Guide
Patient Risk Assessment Bracanalysis Colaris Melaris Colaris AP The Testing Process Billing and Insurance Outreach Materials Clinical References and Resources

Comprehensive COLARIS® or MSH6 Analysis
GENETIC VARIANT, FAVOR POLYMORPHISM

This result means that the test identified a common genetic change in MLH1, MSH2 or MSH6 that is presumed, but not yet conclusively proven, to be unrelated to hereditary cancer risk. The term polymorphism refers to genetic variations that are present in at least 1% of the general population and are unrelated to a significantly increased risk of disease. A patient with this result should be managed in the same manner as a patient with a no mutation detected result. Click here for information on a no mutation detected result.

A favor polymorphism result may be reclassified as a definitive no mutation detected by Myriad in the future. If this occurs, Myriad will issue an amended report to the healthcare provider who ordered the test.

Download the Results Patient Education Tool
COLARIS® No Mutation Detected or Favor Polymorphism


« Back to the COLARIS ® Test Results page


Introduction
Informed Consent Case Study
Want to know more?
Background
MLH1 and MSH2 Genes
Cancer Risk
Testing Guidelines
Test Results and Medical Management